News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,211 Results
Type
Article (48131)
Company Profile (339)
Press Release (716724)
Multimedia
Podcasts (130)
Webinars (22)
Section
Business (214571)
Career Advice (2267)
Deals (37068)
Drug Delivery (134)
Drug Development (83780)
Employer Resources (182)
FDA (17207)
Job Trends (15648)
News (361883)
Policy (34208)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2817)
Academic (1)
Accelerated approval (42)
Adcomms (26)
Allergies (167)
Alliances (53207)
ALS (197)
Alzheimer's disease (1784)
Antibody-drug conjugate (ADC) (385)
Approvals (17507)
Artificial intelligence (649)
Autoimmune disease (234)
Automation (52)
Bankruptcy (369)
Best Places to Work (12035)
BIOSECURE Act (20)
Biosimilars (207)
Biotechnology (224)
Bladder cancer (181)
Brain cancer (66)
Breast cancer (697)
Cancer (5424)
Cardiovascular disease (460)
Career advice (1919)
Career pathing (43)
CAR-T (314)
CDC (62)
Celiac Disease (2)
Cell therapy (838)
Cervical cancer (42)
Clinical research (71896)
Collaboration (1992)
Company closure (5)
Compensation (1285)
Complete response letters (72)
COVID-19 (2872)
CRISPR (108)
C-suite (1018)
Cystic fibrosis (155)
Data (7141)
Decentralized trials (3)
Denatured (48)
Depression (159)
Dermatology (58)
Diabetes (563)
Diagnostics (7151)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (310)
Drug pricing (207)
Drug shortages (35)
Duchenne muscular dystrophy (274)
Earnings (93247)
Editorial (65)
Employer branding (23)
Employer resources (161)
Events (124337)
Executive appointments (1078)
FDA (20700)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1681)
Gene editing (228)
Generative AI (58)
Gene therapy (695)
GLP-1 (1070)
Government (4900)
Grass and pollen (8)
Guidances (399)
Healthcare (19888)
HIV (77)
Huntington's disease (54)
IgA nephropathy (93)
Immunology and inflammation (282)
Immuno-oncology (83)
Indications (158)
Infectious disease (3197)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (282)
Interviews (365)
IPO (17093)
IRA (55)
Job creations (3949)
Job search strategy (1603)
JPM (62)
Kidney cancer (19)
Labor market (93)
Layoffs (578)
Leadership (38)
Legal (8330)
Liver cancer (101)
Longevity (28)
Lung cancer (723)
Lymphoma (411)
Machine learning (54)
Management (65)
Manufacturing (947)
MASH (182)
Medical device (14657)
Medtech (14738)
Mergers & acquisitions (21154)
Metabolic disorders (1454)
mRNA (197)
Multiple sclerosis (175)
NASH (20)
Neurodegenerative disease (397)
Neuropsychiatric disorders (103)
Neuroscience (3216)
Neurotech (1)
NextGen: Class of 2026 (6954)
Non-profit (4761)
Now hiring (73)
Obesity (687)
Opinion (301)
Ovarian cancer (186)
Pain (231)
Pancreatic cancer (260)
Parkinson's disease (348)
Partnered (34)
Patents (569)
Patient recruitment (606)
Peanut (63)
People (62333)
Pharmaceutical (67)
Pharmacy benefit managers (35)
Phase 1 (22487)
Phase 2 (31612)
Phase 3 (23531)
Pipeline (7222)
Policy (323)
Postmarket research (2646)
Preclinical (9629)
Press Release (71)
Prostate cancer (280)
Psychedelics (53)
Radiopharmaceuticals (323)
Rare diseases (1020)
Real estate (6393)
Recruiting (73)
Regulatory (25987)
Reports (55)
Research institute (2600)
Resumes & cover letters (383)
Rett syndrome (32)
RNA editing (20)
RSV (90)
Schizophrenia (168)
Series A (283)
Series B (204)
Service/supplier (15)
Sickle cell disease (109)
Special edition (23)
Spinal muscular atrophy (166)
Sponsored (46)
Startups (3946)
State (2)
Stomach cancer (18)
Supply chain (121)
Tariffs (89)
The Weekly (79)
Vaccines (1128)
Venture capital (104)
Weight loss (445)
Women's health (112)
Worklife (21)
Date
Today (58)
Last 7 days (655)
Last 30 days (2747)
Last 365 days (30911)
2026 (8229)
2025 (31170)
2024 (36416)
2023 (41332)
2022 (52620)
2021 (57280)
2020 (55969)
2019 (48939)
2018 (36920)
2017 (33942)
2016 (33671)
2015 (39854)
2014 (33413)
2013 (28537)
2012 (30788)
2011 (31397)
2010 (29277)
Location
Africa (819)
Alabama (93)
Alaska (7)
Arizona (342)
Arkansas (15)
Asia (43167)
Australia (7215)
California (12489)
Canada (3541)
China (1275)
Colorado (533)
Connecticut (537)
Delaware (378)
Europe (95835)
Florida (1864)
Georgia (409)
Hawaii (3)
Idaho (66)
Illinois (994)
India (82)
Indiana (583)
Iowa (23)
Japan (500)
Kansas (133)
Kentucky (47)
Louisiana (41)
Maine (73)
Maryland (1508)
Massachusetts (9036)
Michigan (374)
Minnesota (699)
Mississippi (7)
Missouri (150)
Montana (36)
Nebraska (29)
Nevada (139)
New Hampshire (89)
New Jersey (3330)
New Mexico (31)
New York (3294)
North Carolina (1613)
North Dakota (10)
Northern California (6144)
Ohio (378)
Oklahoma (24)
Oregon (44)
Pennsylvania (2515)
Puerto Rico (27)
Rhode Island (51)
South America (1206)
South Carolina (78)
South Dakota (1)
Southern California (4915)
Tennessee (204)
Texas (1979)
United States (44507)
Utah (377)
Vermont (1)
Virginia (303)
Washington D.C. (81)
Washington State (1012)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
765,211 Results for "genesis technology group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
This week’s Capitol Hill meetings come on the heels of rejections of ultra-rare disease drugs developed by Biohaven and Saol Therapeutics. Physicians and patient groups implored the FDA to expedite these treatments.
February 27, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
January 8, 2026
·
4 min read
Press Releases
Genesys Spine Announces Launch of the SIros-X™ System for Sacroiliac Joint Fusion and Pelvic Fixation of Pedicle Screw Constructs
April 1, 2026
·
2 min read
Press Releases
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
February 1, 2026
·
4 min read
Press Releases
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
March 24, 2026
·
1 min read
Press Releases
Genesys Spine Announces Positive Prospective Study Results for SIros® Lateral SI Joint Fusion System
February 8, 2026
·
2 min read
Press Releases
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe
January 7, 2026
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
March 12, 2026
·
5 min read
Press Releases
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
March 4, 2026
·
19 min read
Business
Tim Czartoski Appointed as CEO of Genesis Innovation Group
Genesis Innovation Group is excited to announce the appointment of Tim Czartoski as Chief Executive Officer effective April 1, 2024, and serving in an advisory role until that time.
January 22, 2024
·
3 min read
1 of 76,522
Next
